Skip to main content
Open Biology logoLink to Open Biology
. 2022 Mar 9;12(3):210219. doi: 10.1098/rsob.210219

Key thermally dimorphic fungal pathogens: shaping host immunity

Maxine A Höft 1,2,3,, Lucian Duvenage 1,2,3,, J Claire Hoving 1,2,3,
PMCID: PMC8905152  PMID: 35259948

graphic file with name rsob210219.thumb.jpg

Keywords: antifungal immunity, dimorphic fungi, C-type lectin receptor, C‐type lectin receptors (CLR), toll‐like receptors (TLR)

Abstract

Exposure to fungal pathogens from the environment is inevitable and with the number of at-risk populations increasing, the prevalence of invasive fungal infection is on the rise. An interesting group of fungal organisms known as thermally dimorphic fungi predominantly infects immunocompromised individuals. These potential pathogens are intriguing in that they survive in the environment in one form, mycelial phase, but when entering the host, they are triggered by the change in temperature to switch to a new pathogenic form. Considering the growing prevalence of infection and the need for improved diagnostic and treatment approaches, studies identifying key components of fungal recognition and the innate immune response to these pathogens will significantly contribute to our understanding of disease progression. This review focuses on key endemic dimorphic fungal pathogens that significantly contribute to disease, including Histoplasma, Coccidioides and Talaromyces species. We briefly describe their prevalence, route of infection and clinical presentation. Importantly, we have reviewed the major fungal cell wall components of these dimorphic fungi, the host pattern recognition receptors responsible for recognition and important innate immune responses supporting adaptive immunity and fungal clearance or the failure thereof.

1. Introduction

Fungi can be found in almost every environment on earth and are particularly abundant in organic substrates such as soil and plant debris. Despite the millions of fungal species that humans are exposed to, only an estimated 600 species can colonize our bodies or cause opportunistic infection [1]. Infection may arise from commensal overgrowth leading to fungal dysbiosis or from exposure to environmental fungal pathogens [2], with the increasing number of immunocompromised patients being particularly vulnerable. Over millions of years, fungi have evolved and adapted to survive stressors in their environment. They have developed mechanisms to alter their cell shape and form, as well as stress responses and developmental strategies as they react to triggers in their immediate environment. Although many pathogenic fungi are able to alter their morphology as part of their lifecycle, relatively fewer species are considered to be truly dimorphic. The morphological shift in these pathogens is triggered by a change in temperature when entering the host. These pathogens are thermally dimorphic fungi.

These dimorphic fungi have adapted to switch between multicellular filamentous growth or hyphae to unicellular growth forms or yeasts. Dimorphic fungi are found in three main phyla, namely: Ascomycota, Basidiomycota and Zygomycota. There are different environmental stimuli that trigger this strict transition to generate either a hyphal or yeast morphology. While there are many fungi that show aspects of dimorphism, in this review, we will focus on a specific group of fungi belonging to the phyla Ascomycota that exhibit a trait known as thermal dimorphism. Thermally dimorphic fungi are generally found in the soil growing at 22–25°C as mycelia that generate conidia, which are released into the air by wind and soil disruptions along with hyphal fragments. Transition into the yeast phase (or spherules for Coccidioides spp.) occurs at 37°C upon inhalation by the host into the lungs, which can lead to infection [3]. The symptoms of infection can vary; they can be mild and undetected or develop into more serious conditions such as pneumonia, acute respiratory distress syndrome and disseminated disease [3]. The severity of disease depends on exposure and the immune status of the individual, with immunocompromised patients at higher risk of severe disease and death. Thermally dimorphic fungi produce conidia that are responsible for geographical dispersal and host infection. However, it is the transition into yeast form that drives pathogenicity, as these organisms have evolved to alter their cell wall components and proteins to survive at mammalian body temperature and evade immune responses. The main thermally dimorphic pathogens of humans are globally distributed and include Histoplasma capsulatum, Blastomyces dermatiditis, Coccidioides immitis/posadasii, Paracoccidioides brasiliensis/lutzii, Talaromyces marneffei (formerly known as Penicillium marneffei), Sporothrix schenckii and newly identified, Emergomyces spp. These organisms are primary pathogens, but for this review, we will focus on key pathogens that cause the most infections, including, Histoplasma Coccidioides and Talaromyces spp.

2. Prevalence and route of infection

Very few fungal infections are notifiable diseases and therefore, precise information on their prevalence throughout the world is very limited. In fact, until recently, Coccidioides was the only nationally notifiable disease with the CDC in the USA. However, the WHO is generating a priority list of fungal pathogens of public health importance, and this will likely improve the epidemiological data generated for these pathogens. Histoplasmosis, caused by Histoplasma capsulatum, is primarily a respiratory infection, but in patients with impaired T-cell function, it can progress to a life-threatening systemic infection. In some parts of Latin America, the deaths resulting from histoplasmosis among HIV/AIDS patients outnumber those from tuberculosis [4]. The distribution of H. capsulatum is worldwide but it is highly endemic in central North America (especially the USA Midwest) and South America. Considering the high burden of both tuberculosis and advanced HIV disease in sub-Saharan Africa, it is possible that the incidence of Histoplasmosis is higher than previously anticipated, but not being detected. Coccidioidomycosis, also known as Valley fever, is a disease caused by Coccidioides immitis (endemic to Northern Mexico and both central and southern California) and Coccidioides posadasii (detected throughout Arizona, Mexico, Texas and other regions of South America). Exposure to the fungus is common, with an estimated 40% of the population in hyperendemic areas infected [5]. Most immunocompetent individuals exposed are asymptomatic, some experiencing mild symptoms, and they can clear the infection without medical intervention. However, in certain endemic areas, Coccidioides spp. has been reported to be a common cause of community-acquired pneumonia, requiring antifungal treatment [6]. Valley fever, referring to the infection of the lungs, is more common, but in severe cases, disseminated coccidioidomycosis can occur. While Histoplasma spp. and Coccidioides spp. can cause disease in both immunocompetent and immunocompromised individuals, Talaromyces marneffei [7] is an AIDS-defining illness in South and Southeast Asia. The endemic regions of the fungal disease include Northern Thailand, Southern China, Vietnam, Northern India, Hong Kong and Taiwan [8]. Like Histoplasma spp., T. marneffei can disseminate from the lung to other organs, with the potential to reactivate at a later stage, but infection in healthy individuals is not common.

Histoplasma spp. are soil-dwelling fungi, found particularly in moist soils of river valleys and in bird or bat guano, with particularly high concentrations in caves [9]. Similarly, Coccidioides spp. are found in dust, but the low numbers isolated from soil suggest that this organism is better adapted to an animal host. It has not yet been established if Talaromyces spp. occur in the soil, but it is known to infect wild rodents such as the bamboo rat, constituting a reservoir in endemic countries [10,11]. Infection with Histoplasma spp. and Talaromyces spp. occurs through the inhalation of conidia and a shift in temperature inside the host triggers a switch to the pathogenic yeast form. Uniquely, Coccidioides spp. form arthoconidia, which transition into pathogenic spherules in the host [12].

Most patients infected with Histoplasma spp. have no symptoms. In cases of inhalation of a large inoculum of conidia, acute infection may develop, characterized by fevers, malaise, dry cough and lymphadenopathy. Systemic infection develops in approximately 1 in 2000 acute cases and clinical presentation can be quite diverse due to the ability of the fungus to colonize several organs: lung, bone marrow, skin and gastrointestinal tract [13]. For Coccidioides spp., infected individuals generally present with symptoms 1–3 weeks after exposure, which may include the development of a cough, shortness of breath, fever, night sweats, fatigue, headache, muscle or joint pain and skin rash on legs or upper body. Common infected tissues include bones, joints, meninges and skin; dissemination to pericardium, abdomen, adnexa and larynx has been reported, although less commonly [14]. Similarly, Talaromyces spp. are usually cleared by the immunocompetent host within 2–3 weeks. However, impaired T cell function leads to systemic infection, as shown in T cell-deficient hosts [15]. Systemic infection with Talaromyces spp. is life-threatening, with one of the highest mortality rates of AIDS-defining illnesses [16]. Clinical manifestations of disseminated infection include fever, weight loss, skin lesions and hepatomegaly. Skin lesions on the face and neck are characteristic (approximately 85% of patients) as the fungus colonizes the skin [17]. Misdiagnoses are common in the absence of widely available diagnostic tools [18] and highlight the important need to improve tests, which should be widely available.

3. The dimorphic fungal cell wall

The fungal cell wall is a protective barrier against environmental stresses and functions to maintain intracellular turgor pressure. Across fungal species, there are carbohydrate polymers in common that serve to maintain the structural integrity of the cell wall. Thermally dimorphic fungi share many of these core components such as chitin—a polymer of N-acetyl glucosamine—and β-(1,3) glucan (table 1). β-(1,6) glucan, shown in Saccharomyces cerevisiae to be lower in abundance and to cross-link multiple cell wall layers, such as chitin to β-(1,3) glucan layers (table 1) [36]. These polymers form a structural inner layer, upon which an outer cell wall layer can be formed (figure 1). Specific to many dimorphic fungi, α-(1,3) glucan is present in this outer cell wall layer [3739]. While mannans are common in other fungal organisms, they have not yet been described for dimorphic fungi. For Aspergillus fumigatus, galactomannan is present as a linear α-mannan which is modified with short chains of β-(1,5) glucofuranose residues [40]. While galactomannan detection in urine is the basis of an enzyme immunoassay diagnostic test for Histoplasmosis [41], whether this is a component of the dimorphic cell wall or only present in a soluble form needs to be clarified. Melanin is also present in the dimorphic organisms discussed here [42,43]. Within dimorphic fungal species, there can be considerable variation in the cell wall composition of the different morphological forms (mycelia, conidia and yeast). The filamentous forms have adapted to survival as free-living environmental organisms, whereas the yeast forms survive at elevated temperatures within the mammalian host, interacting with the immune system [44]. Components of the cell wall which are recognized as foreign by pathogen recognition receptors (PRRs) of the host immune system are referred to as pathogen-associated molecular patterns (PAMPs).

Table 1.

Major pathogen-associated molecular patterns (PAMPs) found on the cell walls of thermally dimorphic fungal pathogens and associated pathogen recognition receptors (PRRs). Relevant references are indicated in the text. Abbreviations: Hsp60, heat-shock protein 60; Yps3, yeast phase-specific protein-3; CR3, complement receptor 3; VLA-5, very late antigen-5; TLR, toll-like receptor; Mp1, mannoprotein 1; DC-SIGN, dendritic cell-specific ICAM-3-grabbing non-integrin; Gp70, glycoprotein-70 kDa; BAD1, blastomyces adhesin-1; MCL, murine macrophage C-type lectin; MR, mannose receptor; SOWgp, spherule outer‐wall glycoprotein.

pathogen phase PAMP PRR references
Histoplasma capsulatum yeast [β-(1,3) glucan]? Dectin-1 [19]
Hsp60 CR3 [20]
cyclophilin-A VLA-5 (dendritic cells) [21]
Yps3 TLR2 [22]
yeast DNA TLR7, TLR9 (dendritic cells) [23]
Talaromyces marneffei conidia unknown TLR1, TLR2, TLR4, TLR6 [24]
Mp1 mannoprotein unknown [25]
conidia/yeast unknown CR3 [26]
yeast Unknown DC-SIGN (dendritic cells) [27]
N-acetyl-β-D-glucosaminyl groups unknown [28]
Coccidioides spp. spherule unknown TLR2 [29]
[β-(1,3) glucan]? Dectin-1 [30]
mannose MR [31,32]
SOWgp ? [3335]

Figure 1.

Figure 1.

Schematic representation of the cell wall of select dimorphic fungi. All common components are shown here, though not all may be present in each species. Chitin and β-(1,3) glucan form the structural core of the cell wall, which may be cross-linked by β-(1,6) glucan. The type of melanin and its distribution can vary by species and its position shown here is speculated, as is the location of β-(1,6) glucan. Alpha-(1,3) glucan is common on the cell wall exterior of dimorphic fungi. Created with BioRender.com.

4. Pathogen-associated molecular patterns

4.1. Chitin

Chitin is a widely conserved structural polymer in the fungal cell wall. For T. marneffei, chitin has been shown to be an essential fungal cell wall component. Cánovas and colleagues demonstrated the importance of myosin (MyoB) in chitin deposition. Defects in MyoB were associated with chitin defects leading to the absence of conidiophore cell types [45]. Although conserved, chitin content can vary greatly between species and between chemotypes of the same species. Furthermore, the level of chitin in the cell wall also changes upon dimorphic switching. For Coccidioides posadasii, particular subsets of chitin synthases are responsible for the production of chitin at different stages of differentiation. Comparing the expression of seven synthase genes, Mandel et al. identified the pattern of expression during morphogenesis. While the genes CpCHS2, CpCHS3 and CpCHS6 were expressed during the saprobic phase, CpCHS1 and CpCHS4 were associated with the pathogenic phase. CpCHS5 and CpCHS7 were found in both phases [46]. The host environment can also influence the chitin cell wall content, as shown recently for Histoplasma spp. [47]. Here Assunção et al. demonstrate that low zinc availability in macrophages increases the chitin and glycan content in fungal cell wall. This causes a smoother cell surface and is suggested to increase pathogenicity by inhibiting the production of cytokines released by the host. Despite the importance of these findings, and even though several proteins in the human host have been shown to interact with chitin, the role of chitin as a PAMP in dimorphic fungal infections remains unclear.

4.2. Melanin

Melanins are a diverse group of high-molecular dark brown or black pigments that act as fungal armour. The two most commonly found melanins in fungi are eumelanin DOPA-melanin and allomelanin-derived DHN-melanin. Little is known about the organization of melanin in cell walls of dimorphic pathogens [48], but the presence of melanin has raised interest in whether it is associated with fungal virulence. For example, Sporothrix schenckii expresses melanin in both the conidial and yeast phase during in vivo infection [49]. Like S. schenckii, pigmented H. capsulatum conidia and yeast have tufts on their exterior surface and resemble the granules seen on S. schenckii conidia [50]. The in vitro production of melanin by H. capsulatum conidia without the addition of phenolic precursors suggests that the pigment may be DHN melanin [42]. However, the genome of T. marneffei, which encodes several laccases associated with both DOPA- and DHN-melanin synthesis, suggests that both are types of melanin are synthesized [5153]. Melanin may also confer resistance to antifungal drugs. Several fungi are stimulated to produce melanin in vitro when grown in the presence of L-DOPA. H. capsulatum was shown to increase resistance to Amphotericin B and caspofungin if stimulated to generate melanin under these conditions [54].

4.3. Beta-glucans

β-glucans are the most abundant fungal cell wall polysaccharides. Due to the highly immunogenic nature of β-(1,3) glucan, concealment or ‘masking’ is a desirable immune evasion strategy, as demonstrated with H. capsulatum [55]. By contrast, β-(1,6) glucan has relatively low abundance in the cell wall and is not considered to have a significant role in the immune response. However, in other non-dimorphic fungal organisms, β-(1,6) glucan is incorporated in branch points in β-(1,3) glucan chains and can influence the degree of branching and molecular weight of β-glucan polymers. Therefore, β-(1,6) glucan is thought to be an important factor in the immuno-stimulatory activity of β-(1,3) glucan, but this has not been shown for thermally dimorphic fungi [56,57].

4.4. Cell wall proteins

Proteins anchored to the cell wall have important functions in cell wall maintenance, nutrient acquisition and stress resistance. Some of these may be recognized by the host immune system and trigger phagocytosis, which, in the case of some fungal pathogens, is a survival strategy due to their preference to multiply within macrophages, and aids in dissemination in the host. Heat-shock proteins (Hsps) are an example of cell wall proteins recognized by the immune system. For example, Hsp60 of H. capsulatum is recognized by complement receptor 3 on macrophages and neutrophils, triggering phagocytosis [20]. Cell wall proteins, such as Mp1 in T. marneffei, are often highly immunogenic and species-specific and are therefore attractive candidates for vaccine and diagnostics development [58]. Similarly, in Coccidioides spp., a spherule-abundant protein (Pmp1), secreted fungal aspartyl proteases (Pep1) and recombinant β-1,3-glucanosyltransferase (Gel1) have all shown promise as effective vaccine targets in the murine model of coccidioidomycosis [5961]. Therefore, identifying cell wall proteins in vaccine strategies is incredibly important.

4.5. Alpha glucans

Increasing evidence suggests that most pathogenic dimorphic fungi display α-(1,3) glucan on their cell wall surface [38,39,55]. However, more information is needed to determine the specific detail of α-(1,3) glucan's contribution to the cell wall structure of other dimorphic organisms such as Coccidioides spp. Furthermore, very little information is available about α-glucan recognition by the host and the associated immune response. However, this cell wall polymer has been shown to be required for virulence in Histoplasma spp. [55,62,63]. Removal of α-(1,3) glucan from the outer cell wall increases immune recognition by Dectin-1, suggesting that α-(1,3) glucan may mask underlying β-(1,3) glucan [64]. Furthermore, the β-glucanase Eng1 trims exposed β-(1,3) glucan and therefore blocks recognition by the host receptor Dectin-1 [19]. Considering that α-(1,3) glucan is a major cell wall component in dimorphic fungi, this is an important area for future research.

5. Dimorphic fungal recognition and associated host response

Phagocytes widely express membrane-bound PRRs that can directly recognize PAMPs on cell wall components of fungi. The nature of fungal dimorphism presents a challenge for immune detection and activation because the form in which the organism enters the host changes. As described above, Histoplasma, Coccidioides and Talaromyces spp. all express chitins and α- and β-glucans in their outer cell wall. It is postulated that these cell components are recognized by a variety of host toll-like receptors (TLRs) and C-type lectin receptors (CLRs) to elicit strong inflammatory responses from local immune cells (figure 2). However, receptors for chitin, α-1,3-glucan or galactose polymers remain to be identified. Several TLRs have been shown to recognize fungal PAMPs and play a role in antifungal immunity, triggering inflammatory responses, mainly working together with CLRs (e.g. Dectin-1 and mannose receptor (MR)).

Figure 2.

Figure 2.

Innate recognition of select thermally dimorphic fungal pathogens and the downstream activation pathways. PRRs on innate immune cells recognize PAMPs during fungal infection. The main PRRs involved in dimorphic fungal recognition are TLRs (such as TLR2, TLR7 and TLR9) and CLRs (such as Dectin-1, Dectin-2, DC-sign and MR). Upon binding and dimorphic fungal recognition of specific fungal PAMPs by TLRs and CLRs, certain downstream intracellular signalling pathways are induced resulting in multiple antifungal immune responses. CARD9, Caspase recruitment domain‐containing protein 9; MyD88, Myeloid differentiation primary response 88; NF‐κB, nuclear factor kappa. Created with BioRender.com.

An elegant review by Ray & Rappleye [65] highlights Histoplasma spp. recognition by host cells and can likely be applied to other similar dimorphic pathogens. However, so much remains unknown, particularly the signalling pathways and cell types involved in the recognition of and response to these dimorphic pathogens. The ability of the innate immune system to trigger an adaptive T cell response is critical to resolution of infection. However, equally important is the role of innate receptors. MyD88, an adaptor protein vital to multiple TLR signalling pathways, was critically required for the host response to Histoplasma spp. MyD88-deficient mice were unable to control the fungal burden and were more susceptible than wild-type, with reduced early inflammatory cytokine production. Interestingly, cell-specific deletion of MyD88 from alveolar macrophages or dendritic cells did not affect mouse survival, suggesting an additional cell type or compensatory mechanisms for clearance [66]. TLR2 binds to a protein, Yps3, expressed on the surface of the yeast phase of H. capsulatum [22]. Yps3 stimulated nuclear factor kappa B (NF-κB) production via TLR2 in both HEK293T cells and in murine microglia; however, further research is required using lung phagocytes or in vivo models to determine the precise role of TLR2. A recent study showed that dendritic cells were able to mount a type I interferon response via TLR7 and TLR9 and proved to be a major driver of the T cell activation required to clear Histoplasma spp. infection [23].

A role for TLR recognition was also demonstrated using myeloid differentiation primary response 88 (MyD88−/−) mice for Coccidioides spp. infection. MyD88−/− mice were more susceptible to Coccidioides spp. infection, with a higher fungal burden in the lung and spleen and impaired cytokine production [67]. Here, interleukin-1R1 (IL-1R1) also uses MyD88 in signalling but not TLR2 was required for clearance. While peritoneal macrophages elicited from TLR2-deficient mice had impaired cytokine production in response to Coccidioides spp. spherules [68], TLR2−/− mice were able to control infection with no increase in susceptibility. Similarly, the susceptibility of mice lacking TLR4 or IL-18R was not affected [69]. By contrast, IL-1R1-deficient mice were reported to have increased disseminated fungal burden, suggesting signalling via IL-1R1 and Myd88 may play a role in coccidioidomycosis immunity in mice [70]. Talaromyces marneffei conidia are recognized by several PRRs. A study using monoclonal antibodies against PRRs on human monocytes to investigate binding to T. marneffei conidia showed that the MR, TLR1, TLR2, TLR4, TLR6, CD14, CD11b and CD18 were all involved in phagocytosis [24]. Recently, a study in AIDS patients in China linked talaromycosis severity with single-nucleotide polymorphisms in TLR2 but not in TLR3 or TLR9 [71].

CLRs have been shown to play key roles in the recognition of fungal pathogens. While evidence is limited for dimorphic fungi, studies suggest a role for CLRs in mediating immunity. CLRs recognize PAMPs on fungal cell wall components and initiate downstream signalling pathways that regulate innate immune responses such as phagocytosis, respiratory burst (resulting in reactive oxygen species (ROS) production), inflammasome activation, neutrophil extracellular trap formation (NETosis), antigen presentation and dendritic cell maturation, as well as the production of inflammatory mediators (e.g. cytokines, chemokines, eicosanoids, etc.) [72]. Both Dectin-1 and Dectin-2 were shown to interact with H. capsulatum, although recognition by Dectin-1 was limited by β-glucan masking. Both receptors, especially Dectin-2, were found to be important for NOD‐, LRR‐ and pyrin domain‐containing protein 3 (NLRP3) inflammasome activation in dendritic cells, leading to IL-1β production. While Dectin-1, MR, DC-SIGN/specific intercellular adhesion molecule‐3‐grabbing nonintegrin‐related 1 (SIGNR1) and FcγR were shown not to be involved in the phagocytosis of yeasts by murine macrophages [73]. Dectin-1 maintained the ability to mediate the production of TNF-α and IL-6 by associating with the complement receptor type 3 (CR3) in murine macrophages [74]. It has long been known that phagocytosis of H. capsulatum by macrophages is dependent on recognition by CR3 and not β-glucan recognition [75]. However, it was only later shown that the major ligand facilitating this binding was heat-shock protein 60 (Hsp60) on the yeast cell wall [20]. For dendritic cells, however, phagocytosis is not mediated through CR3 but rather by the fibronectin receptor VLA-5 [76], which recognizes cyclophilin A, a protein on the surface of the yeast cell wall [21].

Studies investigating the role of CLRs have suggested a role in controlling coccidioidomycosis. First, in vitro studies using RAW 264.7 macrophages overexpressing Dectin-1 infected with C. posadasii spherules produced an increased cytokine response. Similarly, using antibodies to block Dectin-1 in elicited mouse peritoneal macrophages impaired proinflammatory cytokine production [68]. Bronchoalveolar lavage fluid collected from Dectin-1-deficient mice after Coccidioides spp. infection contained reduced levels of IFN-γ and IL-17a cytokines [29]. Associated with this reduction was an increase in fungal burden in the lung and spleen of Dectin-1−/− mice. Linked to the role of Dectin-1, caspase recruitment domain‐containing protein 9 (CARD9) was shown to be vital in triggering Th-1- and Th-17-mediated immune responses towards coccidioidomycosis. Mice that lack CARD9 were highly susceptible to pulmonary and subcutaneous Coccidioides spp. infection and failed to produce protective immunity to the disease [70]. By contrast, Dectin-2 and MR had no apparent role in the resistance to Coccidioides spp. infection in mice, as there was no difference in susceptibility to infection in mice lacking either or both receptors [30]. However, in vitro studies using MR/Dectin-1−/− peritoneal macrophages and bone marrow‐derived dendritic cells (BMDCs), less proinflammatory cytokine production was seen in response to infection with spherules [30]. Furthermore, in vitro studies using human dendritic cells show that MR recognizes C. posadasii spherules and initiates cytokine production [31,32].

For Talaromyces spp., a very recent study has suggested a role for Dectin-1 in initiating signalling through the activation of Syk, which triggered phosphorylation of IκBα and NF-κB. This study was carried out in vitro using THP-1 macrophages and heat-killed T. marneffei [77]. The fact that heat-killed T. marneffei was used and that there is the potential for unnatural exposure of β-glucan polysaccharides to Dectin-1 should be considered. Therefore, further evidence using in vivo models is required to draw conclusions. It was found that MR was important for yeast phagocytosis in human monocyte-derived macrophages, and that DC-SIGN was involved in adhesion to dendritic cells [27]. Interestingly, another study found that MR was not involved in the binding of heat-killed yeasts in murine macrophages. Perhaps heat killing the organism affects the ligand recognized by MR. Phagocytosis was strongly inhibited by competition with wheatgerm agglutinin, suggesting that the yeast phase is recognized by exposed N-acetyl-β-D-glucosaminyl groups [28]. These studies showed that cell wall differences between the morphological forms of dimorphic fungi led to differential engagement of host PRRs. Lastly, the integrin CR3 (a heterodimer of CD11b and CD18) has been shown to recognize a wide variety of fungal pathogens. In response to T. marneffei, murine macrophages were shown to upregulate the expression of CD11b, and the inhibition of CD11b significantly reduced phagocytosis of the yeast. This recognition led to the secretion of IFN-γ, TNF-α, IL-4, IL-10 and IL-12 [25,26]. The surface ligand in T. marneffei that binds to CR3 has not yet been identified.

Receptors on phagocytic cells such as macrophages, neutrophils, monocytes and dendritic cells play a vital role in activating immune cells and promoting fungal killing. Histoplasma and Talaromyces spp. are both intracellular pathogens engulfed by host cells. Although Coccidioides spp. has an intracellular component during infection, the interaction with host cells is predominantly extracellular. Alveolar macrophages are among the first innate immune cells with which H. capsulatum comes into contact in the lung. Recent evidence suggests that dendritic cells are the major antigen-presenting cell during H. capsulatum infection and are important for initiating T-helper type 1 (Th1) responses required to clear the organism [78]. Taken up by macrophages and neutrophils, H. capsulatum yeasts proliferate intracellularly, and within these cells may disseminate to other organs via blood or the lymphatic system. Innate immune cells that are not activated are ineffective in killing intracellular yeasts; only once a Th1 cell-mediated adaptive response has developed may phagocytes contain the infection [79]. Even then, infection may persist and remain dormant in granulomas and can be reactivated following compromised immunity such as immunosuppressive therapy or HIV/AIDS [80]. After the inhalation of the airborne fungal particles, the host phagocytic cells engulf Coccidioides spp. arthroconidia. The arthroconidia is triggered to transition into spherule initials and eventually into multinucleate spherules [81]. Endospores are formed within the spherules that become enlarged, causing the cell wall to rupture upon maturation. Endospores are then released to infect nearby tissue capable of forming new spherules, repeating the life cycle [82]. Phagocytes are able to ingest arthroconidia, sphere initials and endospores; however, mature spherules are too large to engulf. Therefore, Coccidioides spp. have both intracellular and extracellular relationships with the host. Endospores and sphere initials are more susceptible to killing and inhibition of growth by activated phagocytes [83,84]. Lastly, Dong et al. have established that cytokines produced by innate immune cells are critical for resolution of T. marneffei infection in AIDS patients [85]. In a study of 41 AIDS patients infected with T. marneffei, cytokine profiles were tracked over a six-month period after initiation of antifungal therapy. Inflammatory cytokines TNF-α, IFN-γ, IL-6, IL-12, IL-18 and IL-1β were important for resistance of the disease. However, excessive inflammatory responses led to poor patient outcomes. T. marneffei proliferates within macrophages to evade host immunity. A recent study using a zebrafish embryo model found that the conidia are predominantly taken up by macrophages, which supports growth in the yeast phase and protects against the myeloperoxidase fungicidal activity of neutrophils [86]. However, caution should be taken when interpreting these data as the zebrafish model would not represent a host temperature of 37°C and therefore not completely represent true yeast form. Furthermore, T. marneffei was recently shown to promote M2-like polarization of human macrophages, thereby promoting fungal survival. By downregulating SOCS3 expression, or degrading SOCS3, the organism was able to suppress host protective M1 activation. Here, the authors showed that by inhibiting TLR9 activation, this response was partially blocked. This study suggests that the antifungal ability of macrophages depends on their activation status [87].

6. Virulence-associated traits of dimorphic fungi

As β-(1,3) glucan is a key PAMP for fungal recognition and clearance, many fungal pathogens conceal this PAMP to avoid an immune response [55,88]. H. capsulatum has several mechanisms to avoid a Dectin-1 response. A layer of α-(1,3) glucan covers underlying β-(1,3) glucan [89], and the yeast may also secrete endoglucanases such as Eng1 to trim back any exposed β-(1,3) glucan [19]. Independent studies of H. capsulatum chemotype II strains, in which α-(1,3) glucan production has been disrupted, have been shown to exhibit reduced virulence in mouse models of infection [62,90]. A forward genetic screen identified Hsp82 as another important virulence factor, highlighting the importance of heat-shock proteins in resistance to stresses imposed by the host [90]. To survive the ROS produced in the phagosome of macrophages, H. capsulatum produces superoxide dismutase (SOD) and catalase [91]. Without Sod3, an extracellular SOD produced during infection, H. capsulatum cannot survive in activated macrophages. Nearly all mice infected with a lethal dose of wild-type yeast survive for approximately 5 days, whereas almost all mice survive infection with the same dose of the sod3Δ strain after two weeks [92]. The virulence mechanisms of Coccidioides spp. are largely unknown; however, arthroconidia significantly increase in size when transitioning into spherules, which contain between 100 and 300 endospores. The large size of the spherule makes phagocytosis by innate cells challenging. The spherule also contains three unique genes that contribute to virulence factors and host tissue damage: BLG2, SOWgp and MEP1 [3335]. BLG2 cleaves β-1,3-glucan from the spherule cell wall to allow for expansion and growth. Spherule outer-wall glycoprotein (SOWgp) enables the spherule to adhere to host cells by binding to laminin, fibronectin and collagen in the extracellular matrix. The host immune system can recognize SOWgp; however, a Th2 response is activated that assists pathogen survival. Endospores are coated with SOWgp during spherule maturation; however, MEP1 degrades SOWgp, which is another mechanism of preventing immune recognition [3]. For Talaromyces spp., a distinguishing feature when grown in vitro is the production of a soluble red pigment. Laccases are responsible for the formation of melanin-like pigments. The deletion of a laccase gene pbrB in T. marneffei resulted in a strain that was more readily phagocytosed by THP-1 human monocyte cells and stimulated increased cytokine production, suggesting that laccases may have a function in immune evasion [93]. Furthermore, the cell wall mannoprotein Mp1 was found to be important for virulence. Mice infected with Mp1 knockout mutants all survived, in contrast to the 100% mortality when infected with the wild-type strain [94]. To conclusively demonstrate that this was associated with increased survival within macrophages, a direct comparison of phagocytosis rates of wild-type and mutant fungal strains would need to be made. A recent study also found that Mp1 was able to sequester proinflammatory lipid arachidonic acid, thus interfering with host signalling. Mp1 is abundant on the surface of conidia, highly antigenic and found in the sera of infected patients. An enzyme-linked immunosorbent assay with high sensitivity and specificity using an anti-Mp1 antibody was developed, demonstrating that mannoproteins could be an attractive target for diagnostic assay development for other fungi [58].

7. Conclusion, open questions and perspectives

Despite the increase in prevalence and high mortality rates of invasive dimorphic fungal infections, they continue to be misdiagnosed or underreported. Medical mycology has been a neglected research area in general, but even within this, endemic dimorphs receive far less attention than other fungi such as Candida or Cryptococcus. Due to climate change and increased human movement, the endemic range of these pathogens is expanding, and the number of infections may continue to increase [95,96].

The importance of understanding how our immune system interacts with these dimorphic fungal pathogens will provide critical insight into potential vaccine development and therapeutic interventions. Innate immunity is particularly important, as it prevents the vast majority of exposures to fungi in the environment from developing into systemic disease. When systemic disease does occur, innate immune responses shape the induction of adaptive immunity, which is required to clear infections. We have described host–pathogen interactions for some of the most common thermal dimorphic fungal pathogens. However, this field of research is relatively new, and many questions remain unanswered. Much information thus far has been gained from in vitro studies using cell lines, while in vivo data using animal models or clinical studies are lacking. Any observed interactions of fungi with cell monocultures in vitro may not necessarily influence disease progression in a meaningful way; nevertheless, we include this data to serve a record for future studies striving to elucidate the significance of these interactions using in vivo models (table 1).

TLR signalling is a common response to dimorphic fungi, although the role in triggering an immune response requires further investigation. Recognition of H. capsulatum yeast DNA by TLR7/TLR9 is a fascinating recent discovery [23], highlighting the adaptation of the immune system to the intracellular lifestyle of many of these pathogens, which could be exploited in future therapeutic strategies. Recognition by CR3 is common to Histoplasma, Talaromyces and Blastomyces spp. Recognition of β-(1,3) glucan by Dectin-1 does not seem to have a major role in phagocytosis of dimorphic fungi, but rather, may have a role in initiating the adaptive response and clearance once these ligands become more exposed. In general, the role of CLRs is not as clear for these pathogens, as for other medically important fungi. The cell wall of most dimorphic fungi contains α-(1,3)-glucan, which has been shown to mask β-(1,3) glucan recognition; however, receptors for this ligand have not yet been identified, and the manner in which this cell wall component directly shapes the immune response should be a priority for investigation, given its widespread occurrence. As listed in table 1, several fungal ligands of innate immune receptors remain uncharacterized. Some components of the cell wall of these pathogens, which induce a response, engage as yet unidentified receptors. An understanding of these interactions is necessary for the development of potential vaccines. Early diagnostic tools are a cost-effective strategy for preventing severe disease in at-risk populations. Development of diagnostic kits requires an understanding of immunogenic fungal components and their receptors, whether these are innate immune receptors or antibodies. The development of inexpensive and point-of-care diagnostics is particularly important in low- to middle-income countries, where the resources and expertise for PCR identification may not be widely available. Despite these considerable challenges and unanswered questions, recent improvements in diagnostics and their increased availability in endemic areas are promising signs. For example, the development of the enzyme-linked immunosorbent assay for diagnosis of disseminated Histoplasmosis and it simplementation in Latin America are considerable steps forward in recognizing and fighting infection [97], together with creating awareness of the problem, such as the global call for talaromycosis to be recognized as a neglected tropical disease [98]. With commitment from funders, policy makers, researchers and industry, the control of these endemic dimorphic pathogens is feasible and thereby protecting vulnerable populations.

Data accessibility

This article has no additional data.

Authors' contributions

M.A.H.: conceptualization and writing—original draft; L.D.: conceptualization and writing—original draft; J.C.H.: conceptualization, funding acquisition, project administration, resources, supervision and writing—review and editing.

All authors gave final approval for publication and agreed to be held accountable for the work performed therein.

Competing interests

We declare we have no competing interests.

Funding

M.A.H is supported by the National Research Foundation of South Africa, the Oppenheimer Memorial Trust and Carnegie Corporation; L.D. is supported by the University of Cape Town URC fellowship; J.C.H. is supported by the Wellcome Trust (209293) and Carnegie Corporation.

References

  • 1.Limon JJ, Skalski JH, Underhill DM. 2017. Commensal fungi in health and disease. Cell Host Microbe 22, 156-165. ( 10.1016/j.chom.2017.07.002) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Iliev ID, Leonardi I. 2017. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat. Rev. Immunol. 17, 635-646. ( 10.1038/nri.2017.55) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gauthier G, Klein BS. 2008. Insights into fungal morphogenesis and immune evasion. Microbe Magazine 3, 416-423. ( 10.1128/microbe.3.416.1) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Rodrigues AM, et al. 2020. The global epidemiology of emerging Histoplasma species in recent years. Stud. Mycol. 97, 100095. ( 10.1016/j.simyco.2020.02.001) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Nguyen C, Barker BM, Hoover S, Nix DE, Ampel NM, Frelinger JA, Orbach MJ, Galgiani JN. 2013. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of Coccidioidomycosis. Clin. Microbiol. Rev. 26, 505-525. ( 10.1128/cmr.00005-13) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Valdivia L, Nix D, Wright M, Lindberg E, Fagan T, Lieberman D, Stoffer TP, Ampel N, Galgiani J. 2006. Coccidioidomycosis as a common cause of community-acquired pneumonia. Emerg. Infect. Dis. 12, 958. ( 10.3201/eid1206.060028) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Lau S, Tsang CC, Woo P. 2017. Talaromyces marneffei genomic, transcriptomic, proteomic and metabolomic studies reveal mechanisms for environmental adaptations and virulence. Toxins 9, 192. ( 10.3390/toxins9060192) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cao C, Xi L, Chaturvedi V. 2019. Talaromycosis (Penicilliosis) due to Talaromyces (Penicillium) marneffei: insights into the clinical trends of a major fungal disease 60 years after the discovery of the pathogen. Mycopathologia 184, 709-720. ( 10.1007/s11046-019-00410-2) [DOI] [PubMed] [Google Scholar]
  • 9.Woods JP. 2016. Revisiting old friends: developments in understanding Histoplasma capsulatum pathogenesis. J. Microbiol. 54, 265-276. ( 10.1007/s12275-016-6044-5) [DOI] [PubMed] [Google Scholar]
  • 10.Huang X, He G, Lu S, Liang Y, Xi L. 2015. Role of Rhizomys pruinosus as a natural animal host of Penicillium marneffei in Guangdong, China. Microb. Biotechnol. 8, 659-664. ( 10.1111/1751-7915.12275) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Li X, Yang Y, Zhang X, Zhou X, Lu S, Ma L, Lu C, Xi L. 2011. Isolation of Penicillium marneffei from soil and wild rodents in Guangdong, SE China. Mycopathologia 172, 447-451. ( 10.1007/s11046-011-9443-5) [DOI] [PubMed] [Google Scholar]
  • 12.Munoz-Hernandez B, Palma-Cortes G, Cabello-Gutierrez C, Martinez-Rivera MA. 2014. Parasitic polymorphism of Coccidioides spp. BMC Infect. Dis. 14, 213. ( 10.1186/1471-2334-14-213) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Assi MA, Sandid MS, Baddour LM, Roberts GD, Walker RC. 2007. Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine 86, 162-169. ( 10.1097/md.0b013e3180679130) [DOI] [PubMed] [Google Scholar]
  • 14.Sil A, Andrianopoulos A. 2015. Thermally dimorphic human fungal pathogens—polyphyletic pathogens with a convergent pathogenicity trait. Cold Spring. Harb. Perspect. Med. 5, a019794. ( 10.1101/cshperspect.a019794) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kudeken N, Kawakami K, Kusano N, Saito A. 1996. Cell-mediated immunity in host resistance against infection caused by Penicillium marneffei. J. Med. Vet. Mycol. 34, 371-378. ( 10.1080/02681219680000671) [DOI] [PubMed] [Google Scholar]
  • 16.Jiang J, et al. 2019. Effects of Talaromyces marneffei infection on mortality of HIV/AIDS patients in southern China: a retrospective cohort study. Clin. Microbiol. Infect. 25, 233-241. ( 10.1016/j.cmi.2018.04.018) [DOI] [PubMed] [Google Scholar]
  • 17.Vanittanakom N, Sirisanthana T. 1997. Penicillium marneffei infection in patients infected with human immunodeficiency virus. Curr. Top. Med. Mycol. 8, 35-42. ( 10.1128/CMR.19.1.95-110.2006) [DOI] [PubMed] [Google Scholar]
  • 18.Pruksaphon K, Intaramat A, Ratanabanangkoon K, Nosanchuk JD, Vanittanakom N, Youngchim S. 2020. Diagnostic laboratory immunology for talaromycosis (penicilliosis): review from the bench-top techniques to the point-of-care testing. Diagn. Microbiol. Infect. Dis. 96, 114959. ( 10.1016/j.diagmicrobio.2019.114959) [DOI] [PubMed] [Google Scholar]
  • 19.Garfoot AL, Shen Q, Wuthrich M, Klein BS, Rappleye CA. 2016. The Eng1 β-Glucanase enhances Histoplasma virulence by reducing β-glucan exposure. mBio. 7, e01388-15. ( 10.1128/mBio.01388-15) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Long KH, Gomez FJ, Morris RE, Newman SL. 2003. Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J. Immunol. 170, 487-494. ( 10.4049/jimmunol.170.1.487) [DOI] [PubMed] [Google Scholar]
  • 21.Gomez FJ, Pilcher-Roberts R, Alborzi A, Newman SL. 2008. Histoplasma capsulatum cyclophilin A mediates attachment to dendritic cell VLA-5. J. Immunol. 181, 7106-7114. ( 10.4049/jimmunol.181.10.7106) [DOI] [PubMed] [Google Scholar]
  • 22.Aravalli RN, Hu S, Woods JP, Lokensgard JR. 2008. Histoplasma capsulatum yeast phase-specific protein Yps3p induces toll-like receptor 2 signaling. J. Neuroinflamm. 5, 30. ( 10.1186/1742-2094-5-30) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Van Prooyen N, Henderson CA, Hocking Murray D, Sil A. 2016. CD103+ conventional dendritic cells are critical for TLR7/9-dependent host defense against histoplasma capsulatum, an endemic fungal pathogen of humans. PLoS Pathog. 12, e1005749. ( 10.1371/journal.ppat.1005749) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Srinoulprasert Y, Pongtanalert P, Chawengkirttikul R, Chaiyaroj SC. 2008. Engagement of Penicillium marneffei conidia with multiple pattern recognition receptors on human monocytes. Microbiol. Immunol. 53, 162-172. ( 10.1111/j.1348-0421.2008.00102.x) [DOI] [PubMed] [Google Scholar]
  • 25.Cao L, Chan C-M, Lee C, Sai-Yin Wong S, Yuen KY. 1998. MP1 Encodes an abundant and highly antigenic cell wall mannoprotein in the pathogenic fungus Penicillium marneffei. Infect. Immun. 66, 966-973. ( 10.1128/iai.66.3.966-973.1998) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hu Y, Lu S, Xi L. 2020. Murine macrophage requires CD11b to recognize Talaromyces marneffei. Infect. Drug Resistance 13, 911-920. ( 10.2147/IDR.S237401) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Ngaosuwankul P, Pongtanalert P, Engering A, Chaiyaroj SC. 2008. Differential gene expression profiles of human monocyte-derived antigen presenting cells in response to Penicillium marneffei: roles of DC-SIGN (CD209) in fungal cell uptake. Asian Pac. J. Allergy Immunol. 26, 151-163. [PubMed] [Google Scholar]
  • 28.Rongrungruang Y, Levitz SM. 1999. Interactions of Penicillium marneffei with human leukocytes in vitro. Infect. Immun. 67, 4732-4736. ( 10.1128/IAI.67.9.4732-4736.1999) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Viriyakosol S, Jimenez Mdel P, Gurney MA, Ashbaugh ME, Fierer J. 2013. Dectin-1 is required for resistance to coccidioidomycosis in mice. mBio 5, e00597-12. ( 10.1128/mBio.00597-12) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Viriyakosol S, Jimenez MDP, Saijo S, Fierer J. 2014. Neither Dectin-2 nor the mannose receptor is required for resistance to Coccidioides immitis in mice. Infect. Immun. 82, 1147-1156. ( 10.1128/iai.01355-13) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dionne SO, Podany AB, Ruiz YW, Ampel NM, Galgiani JN, Lake DF. 2006. Spherules derived from Coccidioides posadasii promote human dendritic cell maturation and activation. Infect. Immun. 74, 2415-2422. ( 10.1128/iai.74.4.2415-2422.2006) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Ampel NM, Nelson DK, Li L, Dionne SO, Lake DF, Simmons KA, Pappagianis D. 2005. The Mannose receptor mediates the cellular immune response in human Coccidioidomycosis. Infect. Immun. 73, 2554-2555. ( 10.1128/iai.73.4.2554-2555.2005) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cole GT, Kirkland TN, Franco M, Zhu S, Yuan L, Sun SH, Hearn VM. 1988. Immunoreactivity of a surface wall fraction produced by spherules of Coccidioides immitis. Infect. Immun. 56, 2695-2701. ( 10.1128/iai.56.10.2695-2701.1988) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hung CY, Yu JJ, Seshan KR, Reichard U, Cole GT. 2002. A parasitic phase-specific adhesin of Coccidioides immitis contributes to the virulence of this respiratory fungal pathogen. Infect. Immun. 70, 3443-3456. ( 10.1128/IAI.70.7.3443-3456.2002) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hung CY, Seshan KR, Yu JJ, Schaller R, Xue J, Basrur V, Gardner MJ, Cole GT. 2005. A metalloproteinase of Coccidioides posadasii contributes to evasion of host detection. Infect. Immun. 73, 6689-6703. ( 10.1128/IAI.73.10.6689-6703.2005) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kollar R, Reinhold BB, Petrakova E, Yeh HJ, Ashwell G, Drgonova J, Kapteyn JC, Klis FM, Cabib E. 1997. Architecture of the yeast cell wall β(1→6)-glucan interconnects mannoprotein, β(1→3)-glucan, and chitin. J. Biol. Chem. 272, 17 762-17 775. ( 10.1074/jbc.272.28.17762) [DOI] [PubMed] [Google Scholar]
  • 37.San-Blas G, Ordaz D, Yegres FJ. 1978. Histoplasma capsulatum: chemical variability of the yeast cell wall. Sabouraudia 16, 279-284. ( 10.1080/00362177885380381) [DOI] [PubMed] [Google Scholar]
  • 38.Hogan LH, Klein BS. 1994. Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect. Immun. 62, 3543-3546. ( 10.1128/iai.62.8.3543-3546.1994) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.San-Blas G, San-Blas F, Serrano LE. 1977. Host-parasite relationships in the yeastlike form of Paracoccidioides brasiliensis strain IVIC Pb9. Infect. Immun. 15, 343-346. ( 10.1128/iai.15.2.343-346.1977) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Latge JP, Mouyna I, Tekaia F, Beauvais A, Debeaupuis JP, Nierman W. 2005. Specific molecular features in the organization and biosynthesis of the cell wall of Aspergillus fumigatus. Med. Mycol. 43, S15-S22. ( 10.1080/13693780400029155) [DOI] [PubMed] [Google Scholar]
  • 41.Theel ES, Jespersen DJ, Harring J, Mandrekar J, Binnicker MJ. 2013. Evaluation of an enzyme immunoassay for detection of Histoplasma capsulatum antigen from urine specimens. J. Clin. Microbiol. 51, 3555-3559. ( 10.1128/jcm.01868-13) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Nosanchuk JD, Gomez BL, Youngchim S, Diez S, Aisen P, Zancope-Oliveira RM, Restrepo A, Casadevall A, Hamilton AJ. 2002. Histoplasma capsulatum synthesizes melanin-like pigments in vitro and during mammalian infection. Infect. Immun. 70, 5124-5131. ( 10.1128/IAI.70.9.5124-5131.2002) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Nosanchuk JD, Yu JJ, Hung CY, Casadevall A, Cole GT. 2007. Coccidioides posadasii produces melanin in vitro and during infection. Fungal Genet. Biol. 44, 517-520. ( 10.1016/j.fgb.2006.09.006) [DOI] [PubMed] [Google Scholar]
  • 44.Trevijano-Contador N, Rueda C, Zaragoza O. 2016. Fungal morphogenetic changes inside the mammalian host. Semin Cell Dev. Biol. 57, 100-109. ( 10.1016/j.semcdb.2016.04.008) [DOI] [PubMed] [Google Scholar]
  • 45.Cánovas D, Boyce KJ, Andrianopoulos A. 2011. The fungal type II myosin in Penicillium marneffei, MyoB, is essential for chitin deposition at nascent septation sites but not actin localization. Eukaryot. Cell 10, 302-312. ( 10.1128/EC.00201-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Mandel MA, Galgiani JN, Kroken S, Orbach MJ. 2006. Coccidioides posadasii contains single chitin synthase genes corresponding to classes I to VII. Fungal Genet. Biol. 43, 775-788. ( 10.1016/j.fgb.2006.05.005) [DOI] [PubMed] [Google Scholar]
  • 47.Assunção LP, Moraes D, Soares L, Silva-Bailão MG, de Siqueira JG, Baeza LC, Báo SN, Soares CM, Bailão AM. 2020. Insights into Histoplasma capsulatum behavior on zinc deprivation. Front. Cell Infect. Microbiol. 30, 573097. ( 10.3389/fcimb.2020.573097) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Gow NAR, Latge JP, Munro CA. 2017. The fungal cell wall: structure, biosynthesis, and function. Microbiol. Spectr. 5. ( 10.1128/microbiolspec.FUNK-0035-2016) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Morris-Jones R, Youngchim S, Gomez BL, Aisen P, Hay RJ, Nosanchuk JD, Casadevall A, Hamilton AJ. 2003. Synthesis of melanin-like pigments by Sporothrix schenckii in vitro and during mammalian infection. Infect. Immun. 71, 4026-4033. ( 10.1128/iai.71.7.4026-4033.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Romero-Martinez R, Wheeler M, Guerrero-Plata A, Rico G, Torres-Guerrero H. 2000. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect. Immun. 68, 3696-3703. ( 10.1128/iai.68.6.3696-3703.2000) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Youngchim S, Hay RJ, Hamilton AJ. 2005. Melanization of Penicillium marneffei in vitro and in vivo. Microbiology 151, 291-299. ( 10.1099/mic.0.27433-0) [DOI] [PubMed] [Google Scholar]
  • 52.Liu D, Wei L, Guo T, Tan W. 2014. Detection of DOPA-melanin in the dimorphic fungal pathogen Penicillium marneffei and its effect on macrophage phagocytosis in vitro. PLoS ONE 9, e92610. ( 10.1371/journal.pone.0092610) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Sapmak A, Boyce KJ, Andrianopoulos A, Vanittanakom N. 2015. The pbrB gene encodes a laccase required for DHN-melanin synthesis in conidia of Talaromyces (Penicillium) marneffei. PLoS ONE 10, e0122728. ( 10.1371/journal.pone.0122728) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Collette JR, Lorenz MC. 2011. Mechanisms of immune evasion in fungal pathogens. Curr. Opin. Microbiol. 14, 668-675. ( 10.1016/j.mib.2011.09.007) [DOI] [PubMed] [Google Scholar]
  • 55.Rappleye CA, Eissenberg LG, Goldman WE. 2007. Histoplasma capsulatum α-(1,3)-glucan blocks innate immune recognition by the β-glucan receptor. Proc. Natl Acad. Sci. USA 104, 1366-1370. ( 10.1073/pnas.0609848104) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bromuro C, et al. 2010. Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 28, 2615-2623. ( 10.1016/j.vaccine.2010.01.012) [DOI] [PubMed] [Google Scholar]
  • 57.Cleary JA, Kelly GE, Husband AJ. 1999. The effect of molecular weight and β-1,6-linkages on priming of macrophage function in mice by (1,3)-β-d-glucan. Immunol. Cell Biol. 77, 395-403. ( 10.1046/j.1440-1711.1999.00848.x) [DOI] [PubMed] [Google Scholar]
  • 58.Cao L, Chan KM, Chen D, Vanittanakom N, Lee C, Chan CM, Sirisanthana T, Tsang DNC, Yuen KY. 1999. Detection of cell wall mannoprotein Mp1p in culture supernatants of Penicillium marneffei and in sera of Penicilliosis patients. J. Clin. Microbiol. 37, 981-986. ( 10.1128/jcm.37.4.981-986.1999) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Orsborn KI, Shubitz LF, Peng T, Kellner EM, Orbach MJ, Haynes PA, Galgiani JN. 2006. Protein expression profiling of Coccidioides posadasii by two-dimensional differential in-gel electrophoresis and evaluation of a newly recognized peroxisomal matrix protein as a recombinant vaccine candidate. Infect. Immun. 74, 1865-1872. ( 10.1128/IAI.74.3.1865-1872.2006) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Tarcha EJ, Basrur V, Hung CY, Gardner MJ, Cole GT. 2006. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice. Infect. Immun. 74, 516-527. ( 10.1128/IAI.74.1.516-527.2006) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Delgado N, Xue J, Yu JJ, Hung CY, Cole GT. 2003. A recombinant β-1,3-glucanosyltransferase homolog of Coccidioides posadasii protects mice against coccidioidomycosis. Infect. Immun. 71, 3010-3019. ( 10.1128/IAI.71.6.3010-3019.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Rappleye CA, Engle JT, Goldman WE. 2004. RNA interference in Histoplasma capsulatum demonstrates a role for α-(1,3)-glucan in virulence. Mol. Microbiol. 53, 153-165. ( 10.1111/j.1365-2958.2004.04131.x) [DOI] [PubMed] [Google Scholar]
  • 63.Reese AJ, Doering TL. 2003. Cell wall α-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Mol. Microbiol. 50, 1401-1409. ( 10.1046/j.1365-2958.2003.03780.x) [DOI] [PubMed] [Google Scholar]
  • 64.Edwards JA, Alore EA, Rappleye CA. 2011. The yeast-phase virulence requirement for α-glucan synthase differs among Histoplasma capsulatum chemotypes. Eukaryot. Cell 10, 87-97. ( 10.1128/EC.00214-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Ray SC, Rappleye CA. 2019. Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition. Semin. Cell Dev. Biol. 89, 91-98. ( 10.1016/j.semcdb.2018.03.009) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Coady A, Sil A. 2015. MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection. Infect. Immun. 83, 1265-1275. ( 10.1128/iai.02619-14) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Viriyakosol S, Walls L, Okamoto S, Raz E, Williams DL, Fierer J. 2018. Myeloid differentiation factor 88 and interleukin-1R1 signaling contribute to resistance to Coccidioides immitis. Infect. Immun. 86, e00028-18. ( 10.1128/IAI.00028-18) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Viriyakosol S, Fierer J, Brown GD, Kirkland TN. 2005. Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on toll-like receptor 2 and dectin-1. Infect. Immun. 73, 1553-1560. ( 10.1128/iai.73.3.1553-1560.2005) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Kirkland TN, Fierer J. 1983. Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection. Infect. Immun. 40, 912-916. ( 10.1128/IAI.40.3.912-916.1983) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Hung CY, Hsu AP, Holland SM, Fierer J. 2019. A review of innate and adaptive immunity to coccidioidomycosis. Med. Mycol. 57, S85-S92. ( 10.1093/mmy/myy146) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Wang M, et al. 2021. The association of TLR2, TLR3, and TLR9 gene polymorphisms with susceptibility to talaromycosis among Han Chinese AIDS patients in Guangdong. Front. Cell Infect. Microbiol. 11, 625461. ( 10.3389/fcimb.2021.625461) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Brown GD, Crocker PR. 2016. Lectin receptors expressed on myeloid cells. Microbiol. Spectr. 4. ( 10.1128/microbiolspec.MCHD-0036-2016) [DOI] [PubMed] [Google Scholar]
  • 73.Lin JS, Huang JH, Hung LY, Wu SY, Wu-Hsieh BA. 2010. Distinct roles of complement receptor 3, dectin-1, and sialic acids in murine macrophage interaction with Histoplasma yeast. J. Leukoc. Biol. 88, 95-106. ( 10.1189/jlb.1109717) [DOI] [PubMed] [Google Scholar]
  • 74.Huang JH, Lin CY, Wu SY, Chen WY, Chu CL, Brown GD, Chuu CP, Wu-Hsieh BA. 2015. CR3 and dectin-1 collaborate in macrophage cytokine response through association on lipid rafts and activation of Syk-JNK-AP-1 pathway. PLoS Pathog. 11, e1004985. ( 10.1371/journal.ppat.1004985) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Bullock WE, Wright SD. 1987. Role of the adherence-promoting receptors, CR3, LFA-1, and p150,95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med. 165, 195-210. ( 10.1084/jem.165.1.195) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Gildea LA, Morris RE, Newman SL. 2001. Histoplasma capsulatum yeasts are phagocytosed via very late antigen-5, killed, and processed for antigen presentation by human dendritic cells. J. Immunol. 166, 1049-1056. ( 10.4049/jimmunol.166.2.1049) [DOI] [PubMed] [Google Scholar]
  • 77.Peng Y, Chen Y, Ma J, Zhou W, Wang Y, Wang Y, Zheng H, Shi W. 2022. Role and mechanism of the dectin-1-mediated Syk/NF-κB signaling pathway in Talaromyces marneffei infection. Exp. Ther. Med. 23, 84. ( 10.3892/etm.2021.11007) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Szymczak WA, Deepe GS Jr. 2010. Antigen-presenting dendritic cells rescue CD4-depleted CCR2-/- mice from lethal Histoplasma capsulatum infection. Infect. Immun. 78, 2125-2137. ( 10.1128/IAI.00065-10) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Gildea LA, Gibbons R, Finkelman FD, Deepe GS Jr. 2003. Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect. Immun. 71, 3787-3793. ( 10.1128/IAI.71.7.3787-3793.2003) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.McKinsey DS, et al. 1997. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, and pathophysiology. Clin. Infect. Dis. 24, 1195-1203. ( 10.1086/513653) [DOI] [PubMed] [Google Scholar]
  • 81.Ternovoĭ VI, Golotina NB. 1977. Ultrastructure of parasitic forms of the agent of coccidioidomycosis. Zh Mikrobiol. Epidemiol. Immunobiol. 4, 71-77. [PubMed] [Google Scholar]
  • 82.Cole GT, Sun SH. 1985. Arthroconidium-spherule-endospore transformation in Coccidioides immitis. In Fungal dimorphism: with emphasis on fungi pathogenic for humans (eds Szaniszlo PJ, Harris JL), pp. 281-333. Boston, MA: Springer. [Google Scholar]
  • 83.Drutz DJ, Huppert M. 1983. Coccidioidomycosis: factors affecting the host-parasite interaction. J. Infect. Dis. 147, 372-390. ( 10.1093/infdis/147.3.372) [DOI] [PubMed] [Google Scholar]
  • 84.Lee CY, Thompson GR 3rd, Hastey CJ, Hodge GC, Lunetta JM, Pappagianis D, Heinrich V. 2015. Coccidioides endospores and spherules draw strong chemotactic, adhesive, and phagocytic responses by individual human neutrophils. PLoS ONE 10, e0129522. ( 10.1371/journal.pone.0129522) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Dong RJ, Zhang YG, Zhu L, Liu HL, Liu J, Kuang YQ, Wang RR, Li YY. 2019. Innate immunity acts as the major regulator in Talaromyces marneffei coinfected AIDS patients: cytokine profile surveillance during initial 6-month antifungal therapy. Open Forum Infect. Dis. 6, ofz205. ( 10.1093/ofid/ofz205) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Ellett F, Pazhakh V, Pase L, Benard EL, Weerasinghe H, Azabdaftari D, Alasmari S, Andrianopoulos A, Lieschke GJ. 2018. Macrophages protect Talaromyces marneffei conidia from myeloperoxidase-dependent neutrophil fungicidal activity during infection establishment in vivo. PLoS Pathog. 14, e1007063. ( 10.1371/journal.ppat.1007063) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Wei W, et al. 2021. Talaromyces marneffei promotes M2-like polarization of human macrophages by downregulating SOCS3 expression and activating the TLR9 pathway. Virulence 12, 1997-2012. ( 10.1080/21505594.2021.1958470) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Snarr BD, Qureshi ST, Sheppard DC. 2017. Immune recognition of fungal polysaccharides. J. Fungi (Basel) 3, 47. ( 10.3390/jof3030047) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Edwards JA, Zemska O, Rappleye CA. 2011. Discovery of a role for Hsp82 in Histoplasma virulence through a quantitative screen for macrophage lethality. Infect. Immun. 79, 3348-3357. ( 10.1128/IAI.05124-11) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Marion CL, Rappleye CA, Engle JT, Goldman WE. 2006. An α-(1,4)-amylase is essential for α-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol. Microbiol. 62, 970-983. ( 10.1111/j.1365-2958.2006.05436.x) [DOI] [PubMed] [Google Scholar]
  • 91.Holbrook ED, Smolnycki KA, Youseff BH, Rappleye CA. 2013. Redundant catalases detoxify phagocyte reactive oxygen and facilitate Histoplasma capsulatum pathogenesis. Infect. Immun. 81, 2334-2346. ( 10.1128/IAI.00173-13) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Youseff BH, Holbrook ED, Smolnycki KA, Rappleye CA. 2012. Extracellular superoxide dismutase protects Histoplasma yeast cells from host-derived oxidative stress. PLoS Pathog. 8, e1002713. ( 10.1371/journal.ppat.1002713) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Sapmak A, Kaewmalakul J, Nosanchuk JD, Vanittanakom N, Andrianopoulos A, Pruksaphon K, Youngchim S. 2016. Talaromyces marneffei laccase modifies THP-1 macrophage responses. Virulence 7, 702-717. ( 10.1080/21505594.2016.1193275) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94.Woo PCY, et al. 2016. Mp1p is a virulence factor in Talaromyces (Penicillium) marneffei. PLoS Negl. Trop. Dis. 10, e0004907. ( 10.1371/journal.pntd.0004907) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Ashraf N, et al. 2020. Re-drawing the maps for endemic mycoses. Mycopathologia 185, 843-865. ( 10.1007/s11046-020-00431-2) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Van Rhijn N, Bromley M. 2021. The consequences of our changing environment on life threatening and debilitating fungal diseases in humans. J. Fungi 7, 367. ( 10.3390/jof7050367) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Nacher M, et al. 2019. The fight against HIV-associated disseminated histoplasmosis in the Americas: unfolding the different stories of four centers. J. Fungi 5, 51. ( 10.3390/jof5020051) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Narayanasamy S, et al. 2021. A global call for talaromycosis to be recognised as a neglected tropical disease. Lancet Glob. Health 9, E1618-E1622. ( 10.1016/S2214-109X(21)00350-8) [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

This article has no additional data.


Articles from Open Biology are provided here courtesy of The Royal Society

RESOURCES